← Back to Search

Behavioral Intervention

NF for Substance Abuse

N/A

Recruiting

Research Sponsored by Arizona State University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up the outcome measures are assessed in-person at baseline, 2-4 weeks and 3 months

Awards & highlights

Study Summary

"This trial will investigate if using neurofeedback can improve the effectiveness of integrative body-mind training."

Who is the study for?

This trial is for individuals struggling with substance abuse. Specific eligibility criteria are not provided, but typically participants must meet certain health standards and not be involved in other conflicting treatments or studies.Check my eligibility

What is being tested?

The study is examining if neurofeedback (NF) can enhance the effects of integrative body-mind training (IBMT), a meditation-like practice, to help reduce substance use.See study design

What are the potential side effects?

Since NF involves monitoring brain activity and IBMT is a type of mental training, side effects may include discomfort from wearing sensors or stress due to focusing on personal thoughts during sessions.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ the outcome measures are assessed in-person at baseline, 2-4 weeks and 3 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~the outcome measures are assessed in-person at baseline, 2-4 weeks and 3 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and the outcome measures are assessed in-person at baseline, 2-4 weeks and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Intervention effects on brain function using Functional Magnetic Resonance Imaging (fMRI)

Intervention effects on brain grey matter using fMRI

Intervention effects on brain white matter using fMRI

Secondary outcome measures

Intervention effects on addiction behavior using substance use questionnaires in PhenX Toolkit

Trial Design

4Treatment groups

Experimental Treatment

Placebo Group

Group I: NFExperimental Treatment1 Intervention

An evidence-based intervention - NF can not only provide real-time feedback for practice but also target the self-control networks, suggesting the possibility of augmenting IBMT effects via NF.

Group II: IBMT + NFExperimental Treatment2 Interventions

The combined IBMT and NF also show positive effects in reducing substance use.

Group III: IBMTExperimental Treatment1 Intervention

An evidence-based preventive intervention - integrative body-mind training (IBMT) has shown positive effects in reducing stress and improving self-control and brain plasticity. It has bodifulness and mindfulness components.

Group IV: Sham NFPlacebo Group1 Intervention

Sham NF has the same settings as the active NF but does not have correct parameters of stimulation.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

IBMT

2019

N/A

~70

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Arizona State UniversityLead Sponsor

283 Previous Clinical Trials

109,479 Total Patients Enrolled

2 Trials studying Substance Abuse

3,079 Patients Enrolled for Substance Abuse

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies available for patients to participate in this trial?

"According to details on clinicaltrials.gov, this investigation is presently enrolling participants. The trial was first publicized on September 1st, 2023 and underwent modifications as recent as March 15th, 2024."

Answered by AI

What is the current number of participants being recruited for this medical research study?

"Indeed, information available on clinicaltrials.gov confirms the ongoing recruitment of participants for this investigation. The trial was initially disclosed on September 1st, 2023 and last modified on March 15th, 2024. It aims to enroll a total of 35 subjects from one site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Brain Mechanisms of Reducing Polysubstance Use

2023. "Brain Mechanisms of Reducing Polysubstance Use". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06324786.

All > Phoenix > Paid Studies Glendale